Positivity rates for COVID-19 and flu in the community are rising, according to the epidemiological report of Greece’s National Public Health Organization (EODY) for November 9-15.
Hospital admissions for COVID-19 reached 233, up from the previous week. Flu hospitalizations were stable. Over the last week, two new severe flu cases and one new death were recorded.
The report specifically notes the following:
Influenza-Like Illness (ILI), Regardless Of Pathogen
The number of influenza-like illness cases per 1,000 visits remains low but is trending upward.
Severe Acute Respiratory Infection (SARI), Regardless Of Pathogen
The number of SARI cases per 1,000 admissions remains low, with small weekly fluctuations. Last week it rose slightly compared with the previous week.
SARS-CoV-2 Virus, COVID-19 Infection
Positivity across all SARS-CoV-2 diagnostic tests nationwide is trending upward. Over the last week, there was no significant change compared with the previous week.
There were 233 new COVID-19 admissions, up from the previous week (191).
No new intubations or deaths were recorded.
Influenza Virus
Flu positivity in the community, as estimated by the Sentinel primary health care surveillance network, passed 10%, the epidemic threshold that marks seasonal flu activity, rising from the previous week.
Last week, 88 new flu admissions were recorded, with no significant change from the previous week (86).
Two new severe cases of laboratory-confirmed flu requiring intensive care unit treatment were recorded, along with one new death from laboratory-confirmed flu.
In total, since flu recording began this season, 18 cases of laboratory-confirmed flu requiring ICU treatment and five deaths from laboratory-confirmed flu have been recorded.
Respiratory Syncytial Virus (RSV)
Positivity both in the community (Sentinel primary health care surveillance network) and in the SARI surveillance network remains steady at very low levels. Last week, no samples tested positive for RSV, either from community sampling or from the SARI surveillance network.
EODY recommends RSV vaccination for people over 75 and for those in high-risk groups.






